Menu
Not yet recruiting NCT07042555

Efficacy of Cognitive Behavior Therapy for Treatment of Chronic Pelvic Pain in Women

No phase Interventional Chronic Pelvic Pain Syndrome

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: CBT-cp, Pelvic Floor Therapy, Pharmacotherapy, CBT-cp+PFT.
Who it may be relevant to
Registry conditions: Chronic Pelvic Pain Syndrome. Basic parameters: 18 years — 50 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Efficacy of Cognitive Behavior Therapy, Pelvic Floor Therapy and Pharmacotherapy in the Treatment of Chronic Pelvic Pain in Women: A Comparative Study

Overview

The study will employ 4 treatment arms and 1 placebo arm to compare efficacy of CBT, PFT, Pharmacotherapy, Integrated CBT and PFT modalities in the management of chronic pelvic pain in women.

Interventions

  • Behavioral CBT-cp
    The participants in CBT-cp arm will receive weekly sessions of Cognitive Behavior Therapy for Chronic Pain.
  • Other Pelvic Floor Therapy
    The participants in PFT arm will receive weekly sessions of pelvic floor therapy.
  • Drug Pharmacotherapy
    The participants in Pharmacotherapy arm will receive prescription and non prescription pain medication.
  • Combination product CBT-cp+PFT
    The participants in integrated arm will receive weekly sessions of both CBT-cp and PFT.
  • Other Placebo
    The participants in placebo arm will receive sham drug.

Primary outcome measures

  • The Impact of Female Chronic Pelvic Pain Questionnaire (IF-CPPQ) [Time frame: Up to 12 weeks]

Eligibility criteria

Inclusion criteria

Women of reproductive age, Women with CPP having no pathological or anatomical causes, Women with Overactive Bladder Syndrome Women with Vulvodynia.

Exclusion criteria

Women experiencing per-menopause or menopause, Women with medical, or gynecological or hormonal abnormalities, Women with mental disorders, Women who use substances.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Sequential
Masking
Single blind
Primary purpose
Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07042555 · IslUB

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗